AIDS Prevention

AIDS vaccine trials begin in South Africa, Switzerland

Published in Vaccine Weekly, December 10th, 2003

The International AIDS Vaccine Initiative (IAVI) has begun human trials in South Africa and Switzerland to test HIVA.MVA, a candidate vaccine to prevent people uninfected with HIV/AIDS from contracting the disease.

This brings to five the number of countries where this vaccine candidate currently is in trials.

In South Africa, HIVA.MVA is the second preventive AIDS vaccine candidate to begin a trial in the country this month. The trial of HIVA.MVA is being conducted at the Chris Hani Baragwanath Hospital in Soweto and the Medical Research Council in Durban. AIDS vaccine research in South Africa is coordinated by the South African AIDS Vaccine...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2003-12-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry